Highlights from the Society of Urologic Oncology 4th annual meeting.
OBJECTIVE
The 4th annual meeting of the Society of Urologic Oncology (SUO) was held December 5-6, 2003 in Bethesda, Maryland. The meeting was attended by urologists, medical and radiation oncologists, and researchers whose focus is genitourinary (GU) malignancies. More than 500 participants registered for the meeting.


METHODS
The agenda for the SUO meeting included more than 50 speakers and discussion panels, and addressed a broad range of topics in GU oncology. Transcripts of the proceedings and submitted slide presentations were reviewed for content following the meeting, and the highlights were summarized. These written materials can be accessed through the SUO web site at http://societyofurologiconcology.org.


RESULTS
Reviewed session topics included epidemiology of GU malignancies, biomarkers for GU malignancies, cancer genomics, bladder cancer, testis cancer, minimally invasive treatments for GU malignancies, molecular therapeutics and advanced prostate cancer. Significant advances in these fields have directly impacted clinical care and improved patient outcomes across the many disciplines associated with treatment of GU cancers.


CONCLUSIONS
The SUO meeting is unique in its multidisciplinary forum and focus on urological oncology. The 2003 meeting highlighted recent advances in epidemiology, clinical management and emerging molecular approaches in the diagnosis and treatment of urological malignancies with several state-of-the-art presentations.
Coleman
Jonathan
J
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA. colemanj@mail.nih.gov
Franks
Michael E
ME
Grubb
Robert L
RL
Wynberg
Jason
J
Lee
Christopher S D
CS
Behari
Ashish
A
Kim
Chong M
CM
Williams
Christopher
C
Linehan
W Marston
WM
D006801:Humans; D008297:Male; D013736:Testicular Neoplasms / Q000628:therapy; D014565:Urogenital Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy